• AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery

  • Apr 30 2025
  • Length: 18 mins
  • Podcast

AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery

  • Summary

  • Discover how AI and biotech are joining forces to transform drug development—from genomics and CRISPR target validation to machine learning–driven compound design and high-throughput screening. In this episode of TechDaily.AI (brought to you by StoneFly), we cover:

    • Omics Insights: Mining genomics, transcriptomics, proteomics & metabolomics to pinpoint targets
    • Gene Editing: Using CRISPR and CAR-T engineering for precision therapies
    • AI in Drug Design: Leveraging ML/DL for toxicity prediction, ADME modeling & de novo molecule generation
    • Automation & Scale: High-throughput assays, synthetic biology platforms (e.g., engineered yeast)
    • Clinical Acceleration: AI-powered patient matching for faster trials
    • Roadmap & Challenges: Data quality, explainable AI, vendor collaboration & regulatory readiness

    Tune in to learn how this synergy is cutting R&D costs, speeding timelines, and paving the way for personalized medicine.

    Show more Show less
adbl_web_global_use_to_activate_webcro768_stickypopup

What listeners say about AI × Biotech Revolution: How Genomics, CRISPR & Machine Learning Are Accelerating Drug Discovery

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.